Takeda Settles Actos Claims for $2.4 Billions

Takeda Settles Actos Claims for $2.4 Billions

Takeda Pharmaceuticals has agreed to settle most of the approximately 9,000 lawsuits over the company’s diabetes drug Actos for $2.4 billion dollars. The lawsuits allege that Actos caused bladder cancer and that Takeda concealed the cancer risks from patients. The settlement will become effective if 95 percent of the plaintiffs agree to it. [4/30/15]

Search